НовостиBenzingaRaymond James Initiates Coverage On Avalyn Pharma with Outperform Rating, Announces Price Target of $60 Raymond James Initiates Coverage On Avalyn Pharma with Outperform Rating, Announces Price Target of $60 Benzinga 2026.10.02 10:57 (GMT+0) Открыть на Benzinga Другие новости